Health Biotchnology Valuation
| SHPCX Fund | USD 13.02 0.03 0.23% |
At this time, the entity appears to be overvalued. Health Biotchnology retains a regular Real Value of $11.98 per share. The prevalent price of the fund is $13.02. We determine the value of Health Biotchnology from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Overvalued
Today
Please note that Health Biotchnology's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Health Biotchnology retains a regular Real Value of $11.98 per share. The prevalent price of the fund is $13.02. We determine the value of Health Biotchnology from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Health Biotchnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Health Mutual Fund. However, Health Biotchnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.02 | Real 11.98 | Hype 13.02 | Naive 12.84 |
The intrinsic value of Health Biotchnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Health Biotchnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Health Biotchnology Portfolio helps investors to forecast how Health mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health Biotchnology more accurately as focusing exclusively on Health Biotchnology's fundamentals will not take into account other important factors: Health Biotchnology Total Value Analysis
Health Biotchnology Portfolio is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Health Biotchnology fundamentals before making investing decisions based on enterprise value of the companyHealth Biotchnology Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Health suggests not a very effective usage of assets in March.About Health Biotchnology Valuation
Our relative valuation model uses a comparative analysis of Health Biotchnology. We calculate exposure to Health Biotchnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Health Biotchnology's related companies.The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Saratoga Advantage is traded on NASDAQ Exchange in the United States.
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |